Beijing-based bio-pharmaceutical company CANbridge Life Sciences Ltd. has completed US$10 million series A financing from Qiming Venture Partners and TF Capital, a venture fund started by Chinese contract research organization, Hangzhou Tigermed Consulting Co., according to a company announcement. Founded in 2012, CANbridge has been mostly funded by angel investment from U.S. and Chinese life […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.